VDF FutureCeuticals receives FDA’s GRAS “Letter of No Objection” for its coffee fruit ingredient
VDF FutureCeuticals Inc, the global leader in innovative coffee fruit ingredients, received a “no questions” letter from the Food and Drug Administration (FDA) regarding the self-affirmed GRAS (generally recognized as safe) status of Coffeeberry® Coffee Fruit Extract with 40% chlorogenic acids.
The no questions letter reflects the FDA’s fully independent review of VDF FutureCeuticals’ Self Affirmed GRAS dossier and all of the independent safety, toxicology, and chemistry work that has been performed to date in support of the safety assessment of the Coffeeberry® Coffee Fruit Extract.